Table 2 Clinical and laboratory data of 20 pubertal boys with short stature after GH/Letrozole treatment
Subject No. | Age-ranges (y) | BMI (kg/m2) | Height SDS for CA | Bone age(y) | Height SDS for bone age | Testis volume(ml) | Tanner stage | Testosterone (ng/ml) | Estradiol (pg/ml) | Growth velocity (cm/y) | Final height (cm) |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 13–16 | 26.5 | 0.75 | 14.2 | -0.59 | 25.0 | 5 | 6.74 | 1.00 | 6.9 | 170.0 |
2 | 13–16 | 24.1 | 2.38 | 15.7 | 0.06 | 25.0 | 5 | 3.54 | 0.00 | 6.4 | 174.0 |
3 | 10–13 | 21.1 | 1.10 | 14.5 | -1.30 | 20.0 | 4 | 7.14 | 16.00 | 11.9 | 172.5 |
4 | 14–17 | 18.8 | 0.83 | 13.4 | 0.08 | 25.0 | 5 | 7.25 | 23.00 | 10.3 | 175.0 |
5 | 11–14 | 20.7 | 1.12 | 14.6 | -1.01 | 15.0 | 4 | 6.87 | 10.00 | 9.3 | 172.0 |
6 | 13–16 | 21.7 | 1.67 | 16.2 | -0.69 | 21.0 | 5 | 11.28 | 0.00 | 7.5 | 170.0 |
7 | 12–15 | 17.9 | 2.07 | 14.7 | 0.01 | 20.0 | 4 | 2.13 | 5.00 | 11.4 | 172.5 |
8 | 12–15 | 23.3 | 1.80 | 14.1 | 0.17 | 15.0 | 4 | 7.16 | 17.00 | 10.6 | 174.5 |
9 | 11–14 | 25.6 | 1.76 | 13.5 | 0.46 | 21.0 | 4 | 7.10 | 0.00 | 11.4 | 175.0 |
10 | 10–13 | 20.3 | 1.97 | 13.9 | -0.10 | 18.0 | 4 | 一 a | 一 a | 12.6 | 172.0 |
11 | 11–14 | 23.0 | 1.57 | 12.9 | 0.84 | 25.0 | 5 | 10.19 | 14.00 | 10.8 | 170.6 |
12 | 14–17 | 17.9 | 1.55 | 15.4 | -0.60 | 20.0 | 4 | 4.46 | 12.00 | 6.2 | 173.0 |
13 | 13–16 | 21.4 | 1.38 | 14.3 | -0.20 | 25.0 | 5 | 3.22 | 12.00 | 6.3 | 167.5 |
14 | 10–13 | 19.1 | 1.88 | 14.0 | -0.10 | 25.0 | 5 | 7.14 | 0.00 | 12.1 | 173.2 |
15 | 14–17 | 19.9 | 1.80 | 18.3 | -0.69 | 15.0 | 4 | 10.39 | 36.00 | 5.5 | 169.0 |
16 | 13–16 | 25.1 | 1.63 | 14.0 | 0.14 | 25.0 | 5 | 7.60 | 8.00 | 9.8 | 173.5 |
17 | 12–15 | 23.9 | 1.97 | 14.9 | -0.08 | 20.0 | 4 | 7.79 | 5.00 | 10.9 | 178.0 |
18 | 12–15 | 19.2 | -0.49 | 12.1 | 0.15 | 15.0 | 4 | 5.81 | 14.00 | 7.4 | 170.0 |
19 | 12–15 | 26.0 | 1.55 | 13.9 | 0.06 | 25.0 | 5 | 6.57 | 39.00 | 8.6 | 173.0 |
20 | 13–16 | 20.4 | 2.29 | 13.5 | 0.99 | 25.0 | 5 | 6.96 | 35.00 | 10.8 | 178.0 |